← Back to Search

Cardiac Monitoring Device

Portable Cardiac Monitoring for Childhood Cancer Survivors

N/A

Recruiting

Led By Saro H Armenian

Research Sponsored by City of Hope Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 2 years

Awards & highlights

Study Summary

This trial is testing how well two different portable devices detect early heart dysfunction, compared to other available tests. The devices can be used outside of the clinic, which may help detect problems earlier.

Who is the study for?

This trial is for childhood cancer survivors who were part of a previous study (IRB# 14154) and can consent to participate. It's not suitable for those currently on cancer treatment or with certain implants like pacemakers, insulin pumps, cochlear implants, aneurysm clips, neural stimulators, metal in the eye, or other medical devices.Check my eligibility

What is being tested?

The trial tests new portable systems (SphygmoCor® Xcel and Oscar 2™) against standard heart failure screenings like echocardiograms and cardiac MRIs. These devices could detect early heart issues from home use compared to traditional clinic-based tests.See study design

What are the potential side effects?

There are generally no side effects associated with using the SphygmoCor® Xcel and Oscar 2™ monitoring devices. However, stress during MRI may cause discomfort or anxiety; contrast agents used may lead to allergic reactions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Accuracy of ejection fraction (EF) in the clinic setting, and determine its reproducibility at home.

Secondary outcome measures

Cost-effectiveness of tonometry-based screening in the clinic setting and at home.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Screening (echo, CMR, Tonometry-based system)Experimental Treatment4 Interventions

Patients undergo a one time assessment of cardiac function by echo, CMR, and the Tonometry-based system system in the clinic over 4-6 hours, and will be asked to perform their home-based measurements within 1-5 days of the clinical assessment, allowing us to directly compare measurements obtained by survivors to those by research personnel. Patients also complete questionnaires at baseline.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor

565 Previous Clinical Trials

1,921,260 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,658 Previous Clinical Trials

40,924,442 Total Patients Enrolled

1 Trials studying Blood Cancers

70 Patients Enrolled for Blood Cancers

Saro H ArmenianPrincipal InvestigatorCity of Hope Medical Center

3 Previous Clinical Trials

1,266 Total Patients Enrolled

Media Library

Wireless Synchronized Cardiac Function Monitoring Device (Cardiac Monitoring Device) Clinical Trial Eligibility Overview. Trial Name: NCT05138991 — N/A

Blood Cancers Research Study Groups: Screening (echo, CMR, Tonometry-based system)

Blood Cancers Clinical Trial 2023: Wireless Synchronized Cardiac Function Monitoring Device Highlights & Side Effects. Trial Name: NCT05138991 — N/A

Wireless Synchronized Cardiac Function Monitoring Device (Cardiac Monitoring Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05138991 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for the study still open?

"That is correct. Currently, clinicaltrials.gov hosts information suggesting that this research endeavour, which began on June 22nd 2022, remains actively recruiting participants with a goal of 200 patients from one medical facility."

Answered by AI

What is the maximum capacity for participants in this research endeavor?

"Yes, according to clinicaltrials.gov, this medical study launched on June 22nd 2022 and is currently seeking volunteers. 200 patients will be recruited across a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors

2022. "Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05138991.